Borowski K S, Clark E A S, Lai Y, Wapner R J, Sorokin Y, Peaceman A M, Iams J D, Leveno K J, Harper M, Caritis S N, Miodovnik M, Mercer B M, Thorp J M, O'Sullivan M J, Ramin S M, Carpenter M W, Rouse D J, Sibai B
Departments of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa.
University of Utah, Salt Lake City, Utah.
Am J Perinatol. 2015 Oct;32(12):1126-32. doi: 10.1055/s-0035-1549217. Epub 2015 May 8.
The aim of the study is to evaluate the association of steroid metabolism and respiratory gene polymorphisms in neonates exposed to antenatal corticosteroids (ACS) with respiratory outcomes, small for gestational age (SGA), and response to repeat ACS.
This candidate gene study is a secondary analysis of women enrolled in a randomized controlled trial of single versus weekly courses of ACS. Nineteen single nucleotide polymorphisms (SNPs) in 13 steroid metabolism and respiratory function genes were evaluated. DNA was extracted from placenta or fetal cord serum and analyzed with TaqMan genotyping. Each SNP was evaluated for association via logistic regression with respiratory distress syndrome (RDS), continuous positive airway pressure (CPAP)/ventilator use (CPV), and SGA.
CRHBP, CRH, and CRHR1 minor alleles were associated with an increased risk of SGA. HSD11B1 and SCNN1B minor alleles were associated with an increased likelihood of RDS. Carriage of minor alleles in SerpinA6 was associated with an increased risk of CPV. CRH and CRHR1 minor alleles were associated with a decreased likelihood of CPV.
Steroid metabolism and respiratory gene SNPs are associated with respiratory outcomes and SGA in patients exposed to ACS. Risks for respiratory outcomes are affected by minor allele carriage as well as by treatment with multiple ACS.
本研究旨在评估产前接受糖皮质激素(ACS)治疗的新生儿中,类固醇代谢和呼吸基因多态性与呼吸结局、小于胎龄儿(SGA)以及重复使用ACS的反应之间的关联。
这项候选基因研究是对参与ACS单疗程与每周疗程随机对照试验的女性进行的二次分析。评估了13个类固醇代谢和呼吸功能基因中的19个单核苷酸多态性(SNP)。从胎盘或胎儿脐带血清中提取DNA,并使用TaqMan基因分型进行分析。通过逻辑回归评估每个SNP与呼吸窘迫综合征(RDS)、持续气道正压通气(CPAP)/呼吸机使用(CPV)和SGA之间的关联。
CRHBP、CRH和CRHR1的次要等位基因与SGA风险增加相关。HSD11B1和SCNN1B的次要等位基因与RDS可能性增加相关。SerpinA6中次要等位基因的携带与CPV风险增加相关。CRH和CRHR1的次要等位基因与CPV可能性降低相关。
在接受ACS治疗的患者中,类固醇代谢和呼吸基因SNP与呼吸结局和SGA相关。呼吸结局的风险受次要等位基因携带以及多次使用ACS治疗的影响。